Hexima Limited has released a shareholder announcement with updates on the following:
- Lodgment of Prospectus with ASIC
- Management and Board of Director Changes
- First Patient Treated in Phase IIb Clinical Trial
View full announcement (pdf)
Hexima Limited Prospectus (pdf)